Live Breaking News & Updates on Adaptive Biotechnologies Co

Stay updated with breaking news from Adaptive biotechnologies co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Adaptive Biotechnologies Co. (NASDAQ:ADPT) Receives $6.80 Average Price Target from Analysts

Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average […] ....

Kyle Piskel , Stacyl Taylor , Adaptive Biotechnologies Co , Adaptive Biotechnologies Company Profile , Pinnacle Wealth Planning Services Inc , Jpmorgan Chase Co , Adaptive Biotechnologies Corporation , Goldman Sachs Group , First Trust Direct Indexing , Securities Exchange Commission , Manchester Capital Management , Adaptive Biotechnologies , Get Free Report , Marketbeat Ratings , Exchange Commission , Capital Management , Wealth Planning Services , Get Free , Biotechnologies Corporation , Adaptive Biotechnologies Daily ,

Adaptive Biotechnologies (NASDAQ:ADPT) Trading Down 3.8%

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report)’s share price dropped 3.8% on Thursday . The company traded as low as $3.70 and last traded at $3.75. Approximately 393,202 shares changed hands during trading, a decline of 75% from the average daily volume of 1,598,203 shares. The stock had previously closed at $3.90. Wall Street […] ....

Stacyl Taylor , Adaptive Biotechnologies Co , Jpmorgan Chase Co , Securities Exchange Commission , Pinnacle Wealth Planning Services Inc , Manchester Capital Management , First Trust Direct Indexing , Adaptive Biotechnologies Corporation , Goldman Sachs Group , Adaptive Biotechnologies , Get Free Report , Exchange Commission , Capital Management , Wealth Planning Services , Biotechnologies Corporation , Adaptive Biotechnologies Daily ,

Adaptive Biotechnologies Co. (NASDAQ:ADPT) Given Average Rating of "Moderate Buy" by Brokerages

Adaptive Biotechnologies Co. (NASDAQ:ADPT) Given Average Rating of "Moderate Buy" by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Stacyl Taylor , Goldman Sachs Group , Adaptive Biotechnologies Corporation , Massachusetts Financial Services Co , Jpmorgan Chase Co , Securities Exchange Commission , Investment Management , Adaptive Biotechnologies Company Profile , Adaptive Biotechnologies Co , Adaptive Biotechnologies , Get Free Report , Marketbeat Ratings , Exchange Commission , Capital Management , Massachusetts Financial Services , Financial Services , Get Free , Biotechnologies Corporation , Adaptive Biotechnologies Daily ,

Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Sold by Robertson Stephens Wealth Management LLC

Robertson Stephens Wealth Management LLC lessened its stake in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Free Report) by 8.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 183,786 shares of the company’s stock after selling 16,000 shares during the quarter. […] ....

Lewis Asset Management , Securities Exchange Commission , China Universal Asset Management Co , Exchange Commission , Goldman Sachs Group , Savant Capital , Victory Capital Management Inc , Adaptive Biotechnologies Corporation , Jpmorgan Chase Co , Robertson Stephens Wealth Management , Adaptive Biotechnologies Co , Adaptive Biotechnologies , Free Report , Stephens Wealth Management , Universal Asset Management , Capital Management , Get Free Report , Biotechnologies Corporation , Adaptive Biotechnologies Daily , Nasdaq Adpt , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Analysts Set Adaptive Biotechnologies Co. (NASDAQ:ADPT) Target Price at $6.80

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report) has received a consensus rating of “Moderate Buy” from the six research firms that are currently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year price […] ....

Julie Rubinstein , Stacyl Taylor , Jpmorgan Chase Co , First Trust Direct Indexing , Capital Management Inc , Goldman Sachs Group , Adaptive Biotechnologies Co , Mesirow Financial Investment Management Inc , Adaptive Biotechnologies Corporation , Securities Exchange Commission , Adaptive Biotechnologies , Get Free Report , President Julie Rubinstein , Exchange Commission , Financial Investment Management , Get Free , Biotechnologies Corporation , Adaptive Biotechnologies Daily , Nasdaq Adpt ,